[The prognosis of total cavo-pulmonary anastomosis in relation to age at surgery]

G Buheitel1, M Hofbeck, J von der Emde

  • 1Kardiologische Abteilung der Klinik mit Poliklinik für Kinder und Jugendliche, Friedrich-Alexander-Universität Erlangen-Nürnberg. gernot.buheitel@rzmail.uni-erlangen.de

Herz
|August 13, 1999
PubMed

Insights

Performing total cavopulmonary anastomosis (TCPA) surgery earlier, ideally between ages 3-4, improves outcomes in children. Younger patients demonstrated better cardiac output and exercise capacity, with fewer arrhythmias post-surgery. Careful patient selection is crucial to mitigate higher risks in very young children.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Cardiovascular Physiology

Context:

  • Total cavopulmonary anastomosis (TCPA) is a palliative surgical procedure for complex cyanotic heart disease.
  • The optimal timing for TCPA in pediatric patients remains a subject of ongoing research and clinical debate.

Purpose:

  • To investigate the relationship between the age at which children undergo total cavopulmonary anastomosis (TCPA) and their subsequent postoperative outcomes.
  • To determine if earlier surgical intervention is associated with improved long-term results in pediatric patients after TCPA.

Summary:

  • This study analyzed 53 children undergoing TCPA, comparing outcomes between those younger than 4 years and those older.
  • Younger patients experienced higher perioperative mortality but demonstrated better cardiac index, maximal workload capacity, and reduced incidence of arrhythmias post-surgery.
  • Late mortality was observed in older patients who underwent TCPA at ages 8.3 and 9.0 years.

Impact:

  • Findings suggest that performing TCPA at 3-4 years of age is associated with superior functional outcomes in suitable pediatric patients.
  • The study highlights the need to balance the increased intraoperative risks in younger children against the potential for better long-term results.
  • Recommendations are made for early TCPA in carefully selected pediatric cases to optimize long-term cardiac function and quality of life.